Loss of ability to produce IFN-α in response to HIV-1 as monocytes differentiate into macrophages: Induction through a mechanism independent of double-stranded RNA

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2481-2487

  Francis, Mark L ^a   Fan, Xiaoyan S ^b   Meltzer, Monte S ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; VIREMIA; VIRUS CELL INTERACTION;

CELL DIFFERENTIATION; CELLS, CULTURED; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; INTERFERON-ALPHA; MACROPHAGES; MONOCYTES; NEWCASTLE DISEASE VIRUS; PARAINFLUENZA VIRUS 1, HUMAN; POLY I-C; RNA, DOUBLE-STRANDED; RNA, VIRAL;

EID: 0029998789     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Ho, D. D., K. L. Hartshorn, T. R. Rota, C. A. Andrews, J. C. Kaplan, R. T. Schooley, and M. S. Hirsch. 1985. Recombinant human interferon-α suppresses HTLV-III replication in vitro. Lancet 1:602.
2. Poli, G., J. M. Orenstein, A. Kinter, T. M. Folks, and A. S. Fauci. 1989. Interfeton-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 244:575.
3. Yasuda, Y., S. Miyake, S. Kato, M. Kita, T. Kishida, T. Kimura, and K. Ikuta. 1990. Interferon-α treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1. J. Acquired Immune Defic. Syndr. 3:1046.
4. Gendelman, H. E., L. M. Baca, J. Turpin, D. C. Kalter, B. Hansen, J. M. Orenstein, C. W. Dieffenbach, R. M. Friedman, and M. S. Meltzer. 1990. Regulation of HIV replication in infected monocytes by IFN-α. Mechanisms for viral restriction. J. Immunol. 145:2669.
5. Hansen, B. D., P. L. Nara, R. K. Maheshwari, G. S. Sidhu, J. G. Bernbaum, D. Hoekzema, M. S. Meltzer, and H. E. Gendelman. 1992. Loss of infectivity by progeny virus from interferon-α-treated, human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J. Virol. 66:7543.
6. Francis, M. L., M. S. Meltzer, and H. E. Gendelman. 1992. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retroviruses 8:199.
7. Von Sydow, M., A. Sonnerborg, H. Gaines, and O. Strannegard. 1991. Interferon-α and tumor necrosis facor-α in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retroviruses 7:375.
8. Abb, J., R. Zachoval, V. Zachoval, and F. Deinhardl. 1987. HIV antigen, HIV antibody, and serum inteiferon in a patient with encephalopathy. Infection 15: 425.
9. DeStefano, E., R. M. Friedman, A. E. Friedman-Klien, J. J. Goedert, D. Henriksen, O. T. Preble, J. A. Sonnabend, and J. Vilcek. 1982. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J. Infect. Dis. 146:451.
10. Eyster, M. E., J. J. Goedert, M.-C. Poon, and O. T. Preble. 1983. Acid-labile interferon-α; a possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N. Engl. J. Med. 309:583.
11. Goedert, J. J., C. M. Kessler, L. M. Aledort, R. J. Biggar, W. A. Andes, G. C. White II, J. E. Drummond, K. Vaidya, D. L. Mann, M. E. Eyster, M. V. Ragni, M. M. Lederman, A. R. Cohen, G. L. Bray, P. S. Rosenberg, R. M. Friedman, M. W. Hilgartner, W. A. Blattner, B. Kroner, and M. H. Gail. 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med. 321:1141.
12. 2-microglobulin, and neopterin serum levels in patients with Kaposi's sarcoma and AIDS. J. Acquired Immune Defic. Syndr. 4:871.
13. Francis, M. L., and M. S. Meltzer. 1993. Induction of IFN-β by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J. Immunol. 151:2208.
14. SenGupta, D. N., and R. H. Silverman. 1989. Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res. 17:969.
15. Vogel, S. N., R. M. Friedman, and M. M. Hogan. 1991. Measurement of antiviral activity induced by interferons α, β, and γ. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, pp. 6-9.
16. Yeh, T.-J., P. T. McBride, J. C. Overall, Jr., and J. A. Green. 1982. Automated, quantitative cytopathic effect reduction assay for interferon. J. Clin. Microbiol. 16:413.
17. Rubinstein, S., P. C. Familletti, and S. Pestka. 1981. Convenient assay for interferons. J. Virol. 37:755.
18. Faltynek, C. R., L. R. Finch, P. Miller, and W. R. Overton. 1989. Treatment with recombinant IFN-γ decreases cell surface CD4 levels on peripheral blood monocytes and on myelomonocytic cell lines. J. Immunol. 142:500.
19. + T lymphocytes and monocytes. J. Immunol. 138:3817.
20. Kalter, D. C., M. Nakamura, J. A. Turpin, L. M. Baca, D. L. Hoover, C. Dieffenbach, P. Ralph, H. E. Gendelman, and M. S. Meltzer. 1991. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J. Immunol. 146:298.
21. Rich, E. A., I. S. Y. Chen, J. A. Zack, M. L. Leonard, and W. A. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1. J. Clin. Invest. 89:176.
22. Albers, I., H. Kirchner, and I. Domke-Opitz. 1989. Resistance of human blood monocytes to infection with herpes simplex virus. Virology 169:466.
23. Saksela, E., I. Virtanen, T. Hovi, D. S. Secher, and K. Cantell. 1984. Monocyte is the main producer of human leukocyte α interferons following Sendai virus infection. Prog. Med. Virol. 30:78.
24. Linnavuori, K., and T. Hovi. 1987. Herpes simplex virus as an inducer of interferon in human monocyte cultures. Antiviral Res. 8:201.
25. Rosztoczy, I., and M. Papos. 1989. The role of the various human peripheral blood mononuclear cells in the production of Sendai virus-induced interferon (IFN): IFN mRNA studies. J. Interferon Res. 9:349.
26. Gobl, A. E., K. Funa, and G. V. Alm. 1988. Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immunol. 140:3605.
27. Linnavuori, K., and T. Hovi. 1983. Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology 130:1.
28. Kurane, I., and F. A. Ennis. 1988. Production of interferon-α by dengue virus-infected human monocytes. J. Gen. Virol. 69:445.
29. Kikuta, H., A. Nakane, H. Lu, Y. Taguchi, T. Minagawa, and S. Matsumoto. 1990. Interferon induction by human herpesvirus 6 in human mononuclear cells. J. Infect. Dis. 162:35.
30. Krilov, L. R., R. M. Hendry, E. Godfrey, and K. McIntosh. 1987. Respiratory virus infection of peripheral blood monocytes: correlation with aging of cells and interferon production in vitro. J. Gen. Virol. 68:1749.
31. + subsets of natural killer cells: relationship to cytokine production pattern. J. Virol. 67:5879.
32. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J. Immunol. 152:4649.
33. Szebeni, J., C. Dieffenbach, S. M. Wahl, C. N. Venkateshan, A. Yeh, M. Popovic, S. Gartner, L. M. Wahl, M. Peterfy, R. M. Friedman, and J. N. Weinstein. 1991. Induction of interferon-α by human immunodeficiency virus type 1 in human monocyte/macrophage cultures. J. Virol. 65:6362.
34. Capobianchi, M. R., F. De Marco, P. Di Marco, and F. Dianzani. 1988. Acid-labile human interferon-α production by peripheral blood mononuclear cells stimulated by HIV-infected cells. Arch. Virol. 99:9.
35. Gendelman, H. E., L. M. Baca, C. A. Kubrak, P. Genis, S. Burrous, R. M. Friedman, D. Jacobs, and M. S. Meltzer. 1992. Induction of IFN-α in peripheral blood mononuclear cells by HIV-infected monocytes: restricted antiviral activity of the HIV-induced IFN. J. Immunol. 148:422.
36. Lebon, P. 1985. Inhibition of herpes simplex virus type I-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J. Gen. Virol. 66:2781.
37. Charley, B., and H. Laude. 1988. Induction of interferon-α by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1. J. Virol. 62:8.
38. Capobianchi, M. R., H. Ankel, F. Ameglio, R. Paganelli, P. M. Pizzoli, and F. Dianzani. 1992. Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res. Hum. Retroviruses 8:575.
39. Unanue, E. R. 1993. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation. In Fundamental Immunology, 3rd Ed. W. E. Paul, ed. Raven Press, New York. p. 111.
40. Gordon, S., J. Todd, and Z. A. Cohn. 1974. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J. Exp. Med. 139:1228.
41. Johnson, Jr., W. D., B. Mei, and Z. A. Cohn. 1977. The separation, long-term cultivation, and maturation of the human monocyte. J. Exp. Med. 146:1613.
42. Clarkson, S. B., and P. A. Ory. 1988. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J. Exp. Med. 167:408.
43. Valentin, A., S. Matsuda, and B. Asjo. 1990. Characterization of the in virtro maturation of monocytes and susceptibility to HIV infection. AIDS Res. Hum. Retroviruses 6:977.
44. Gendelman, H. E., R. M. Friedman, S. Joe, L. M. Baca, J. A. Turpin, G. Dveksler, M. S. Meltzer, and C. Dieffenbach. 1990. A selective defect of interferon-α production in human immunodeficiency virus-infected monocytes. J. Exp. Med. 172: 1433.
45. Harper, M. E., L. M. Marselle, R. C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83:772.
46. Gendelman, H. E., J. M. Orenstein, L. M. Baca, B. Weiser, H. Burger, D. C. Kalter, and M. S. Meltzer. 1989. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3:475.
47. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
48. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
49. Edlin, B. R., M. H. St. Clair, P. M. Pitha, S. M. Whaling, D. M. King, J. D. Bitran, and R. A. Weinstein. 1992. In vitro resistance to zidovudine and interferon-α in HIV-1 isolates from patients: correlations with treatment duration and response. Ann. Intern. Med. 117:457.
50. Kunzi, M. S., H. Farzadegan, J. B. Margolick, D. Vlahov, and P. M. Pitha. 1995. Identification of human immunodeficiency virus primary isolates resistant to interferon-α and correlation of prevalence to disease progression. J. Infect. Dis. 171:822.
51. Lau, A. S., S. E. Read, and B. R. G. Williams. 1988. Down-regulation of interferon-α but not γ receptor expression in vivo in the acquired immunodeficiency syndrome. J. Clin. Invest. 82:1415.
52. Preble, O. T., A. H. Rook, R. Steis, R. H. Silverman, D. Krause, G. V. Quinnan, H. Masur, J. Jacob, D. Longo, and E. P. Gelmann. 1985. Interferon-induced 2′-5′ oligoadenylate synthetase during interferon-α therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome. J. Infect Dis. 152:457.
53. Kennedy, P. G. E., O. Narayan, Z. Ghotbi, J. Hopkins, H. E. Gendelman, and J. E. Clements. 1985. Persistent expression of Ia antigen and viral genome in visnamaedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J. Exp. Med. 162:1970.
54. Gringeri, A., E. Santagostino, P. M. Mannucci, F. Tradati, D. Cultraro, A. Buzzi, M. Criscuolo, A. David, L. Guillemot, F. Barre-Sinoussi, A. Lachgar, V. Chams, H. Le Coq, M. Fouchard, A. Achour, L. Fall, M. C. Defer, O. Picard, P. Hermans, A. Burny, M. Feldman, C. Chany, J.-F. Zagury, B. Bizzini, and D. Zagury. 1994. A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-interferon-α immunization. J. Acquired Immune Defic. Syndr. 7:978.
55. Voth, R., S. Rossol, K. Klein, G. Hess, K. H. Schutt, H. C. Schroder, K.-H. M. Z. Buschenfelde, and W. E. G. Muller. 1990. Differential gene expression of interferon-α and tumor necrosis factor-α in peripheral blood mononuclear cells from patients with AIDS-related complex and AIDS. J. Immunol. 144:970.
56. Feldman, S. B., M. C. Milone, P. Kloser, and P. Fitzgerald-Bocarsly. 1995. Functional deficiencies in two distinct interferon-α-producing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients. J. Leukocyte Biol. 57:214.
57. Krown, S. E., F. X. Real, S. Cunningham-Rundles, P. L. Myskowski, B. Koziner, S. Fein, A. Mittelman, H. F. Oettgen, and B. Safai. 1983. Preliminary observations on the effect of recombinant leukocyte interferon-α in homosexual men with Kaposi's sarcoma. N. Engl. J. Med. 308:1071.
58. DeWit, R., J. K. M. E. Schattenkerk, C. A. B. Boucher, P. J. M. Bakker, K. H. N. Veenhof, and S. A. Danner. 1988. Clinical and virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 2:1214.
59. Lane, H. C., J. A. Kovacs, J. Feinberg, B. Herpin, V. Davey, R. Walker, L. Deyton, J. A. Metcalf, M. Baseler, N. Salzman, J. Manischewitz, G. Quinnan, H. Masur, and A. S. Fauci. 1988. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet 2:1218.
60. Lane, H. C., V. Davey, J. A. Kovacs, J. Feinberg, J. A. Metcalf, B. Herpin, R. Walker, L. Deyton, R. T. Davey, J. Falloon, M. A. Polis, N. P. Salzman, M. Baseler, H. Masur, and A. S. Fauci. 1990. Interferon-α in patients with asymptomatic human immunodeficiency virus infection: a randomized, placebo-controlled trial. Ann. Intern. Med. 112:805.
61. Schnittman, S. M., S. Vogel, M. Baseler, H. C. Lane, and R. T. Davey, Jr. 1994. A phase I study of interferon-α2b in combination with interleukin-2 in patients with human immunodeficiency virus infection. J. Infect. Dis. 169:981.
62. Frissen, P. H. J., M. E. van der Ende, C. H. H. T. Napel, H. M. Weigel, G. S. Schreij, R. H. Kaufmann, P. P. Koopmans, A. I. M. Hoepelman, J. B. de Boer, G. J. Weverling, G. Haverkamp, P. Dowd, F. Miedema, R. Schuurman, C. A. B. Boucher, and J. M. A. Lange. 1994. Zidovudine and interferon-α combination therapy verses zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type I infection. J. Infect. Dis. 169:1351.